Long-Term Liabilities: The sum of all non-current liabilities.
Dolby Laboratories (DLB) had Long-Term Liabilities of $158.02M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$307.02M |
|
$49.33M |
|
$39.52M |
|
$267.50M |
|
$277.35M |
|
$29.68M |
|
$11.99M |
|
$41.67M |
|
$41.67M |
|
$49.65M |
|
$49.65M |
|
$49.65M |
|
$49.65M |
|
$29.68M |
|
$54.25M |
|
95.87M |
|
97.48M |
|
$0.52 |
|
$0.50 |
|
| Balance Sheet Financials | |
$1.39B |
|
$470.61M |
|
$1.84B |
|
$3.23B |
|
$437.79M |
|
-- |
|
|
Long-Term Liabilities |
$158.02M |
$595.81M |
|
$2.63B |
|
$1.70B |
|
$2.63B |
|
95.46M |
|
| Cash Flow Statement Financials | |
$472.20M |
|
$-10.59M |
|
$-247.24M |
|
$577.75M |
|
$793.36M |
|
$215.61M |
|
$128.51M |
|
$-126.60M |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.17 |
|
-- |
|
-- |
|
-- |
|
-- |
|
87.13% |
|
9.67% |
|
9.67% |
|
-- |
|
13.57% |
|
16.07% |
|
$435.85M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
1.30 |
|
0.93 |
|
97.06 |
|
1.89% |
|
2.91% |
|
1.54% |
|
1.89% |
|
$27.57 |
|
$4.47 |
|
$4.84 |
|